Menzaghi Frederique Ph.D. has filed 5 insider transactions across 1 company since March 2023.
Most recent transaction: a grant/award of 13500 shares of Tvardi Therapeutics, Inc. ($TVRD) on February 01, 2024.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2024 | Tvardi Therapeutics, Inc. | $TVRD | Menzaghi Frederique Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | A | Common Stock | 13500 | $0.00 | 167,247.0000 | 4,512,422 | 8.78% | 0.30% |
| June 23, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S | Common Stock | 2993 | $3.51 | 153,747.0000 | 53,872,038 | 1.91% | 0.01% |
| April 4, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S | Common Stock | 2733 | $4.91 | 156,740.0000 | 53,872,038 | 1.71% | 0.01% |
| March 3, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S | Common Stock | 6802 | $9.71 | 159,473.0000 | 4,471,130 | 4.09% | 0.15% |
| March 1, 2023 | Tvardi Therapeutics, Inc. | $TVRD | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | A | Stock Option (Right to Buy) | 81000 | $0.00 | 81,000.0000 | 4,471,130 | 9999.99% | 1.81% |